Answers are grounded in this paper and cite their sources.
A single PSA at or before age 50 predicts advanced prostate cancer diagnosed up to 30 years later. Use of early PSA to stratify risk would allow a large group of low-risk men to be screened less often but increase frequency of testing on a more limited number of high-risk men. This is likely to improve the ratio of benefit to harm for screening.
No takes yet. Share an insight, caveat, or question.
Lilja et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: